Bai F, He Y F, Niu Y N, Yang R J, Cao J
Department of Cardiology, The First Hospital of Shanxi Medical University & Department of Pharmacology, Basic Medical School, Shanxi Medical University, Taiyuan 030001, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Mar 11;53(2):240-245. doi: 10.19723/j.issn.1671-167X.2021.02.002.
To evaluate whether ultrafine particulates (UFPs) have direct deleterious effects on cardiac function through activating MAPK signaling.
Langendorff-perfused Sprague-Dawley rat hearts were randomly divided into 2 groups (=10/each group). In control group, the rat hearts were perfused with Tyrode's buffer for 40 min; in UFPs-treated group, the hearts were perfused with UFPs at a concentration of 12.5 mg/L. Cardiac function was determined by measuring left ventricular developed pressure (LVDP), left ventricular peak rate of contraction and relaxation (±d/d) and coronary flow (CF). The levels of malondialdehyde (MDA), superoxide dismutase (SOD), total anti-oxidant capacity (TAOC) were detected in order to evaluate cardiac oxidative stress via the thiobarbituric acid assay, water soluble tetrazolium salt assay and colorimetry, respectively. The expressions of p-p38 MAPK, p-ERKs and p-JNKs in the myocardium were observed using immunohistochemical staining and Western blots.
No significant changes in cardiac function were detected before and after the perfusion in control group while UFPs perfused hearts showed a decline in cardiac function in a time-dependent manner (all < 0.05). In UFPs-treated group, LVDP, +d/d, -d/d and CF were statistically reduced from (82.6±2.1) mmHg, (1 624±113) mmHg/s, (1 565±116) mmHg/s, (12.0±0.2) mL/min to (56.8±4.4) mmHg, (1 066±177) mmHg/s, (1 082±134) mmHg/s, (8.7±0.3) mL/min (all < 0.05), respectively. Furthermore, The comparison between the two groups observed that UFPs perfusion caused a significant decrease in cardiac function at 30 and 40 min compared with the control group (all < 0.05). At the end of the perfusion, the level of MDA was increased from (0.98±0.14) nmol/L to (1.95±0.18) nmol/L, while SOD and TAOC were reduced from (12.50±1.87) U/mL and (6.83±1.16) U/mL to (6.50 ±1.04) U/mL and (3.67±0.82) U/mL (all < 0.001) in UFPs group, respectively. In coincidence with these changes, immunohistochemistry and Western blots results showed that the levels of p-p38 MAPK, p-ERKs and p-JNKs in the myocardium significantly increased in UFPs group as compared with control group (all < 0.05).
The results of this study demonstrated that the short-term exposure of UFPs to the isolated rat hearts has direct and acute toxic effects on cardiac function, probably related to attenuation of anti-oxidative capacity and activation of MAPK signaling pathways.
评估超细颗粒物(UFPs)是否通过激活丝裂原活化蛋白激酶(MAPK)信号通路对心脏功能产生直接有害影响。
将经Langendorff灌注的Sprague-Dawley大鼠心脏随机分为2组(每组n = 10)。对照组大鼠心脏用台氏缓冲液灌注40分钟;UFPs处理组心脏用浓度为12.5 mg/L的UFPs灌注。通过测量左心室舒张末压(LVDP)、左心室峰值收缩和舒张速率(±d/d)以及冠状动脉流量(CF)来测定心脏功能。分别通过硫代巴比妥酸法、水溶性四氮唑盐法和比色法检测丙二醛(MDA)、超氧化物歧化酶(SOD)、总抗氧化能力(TAOC)水平,以评估心脏氧化应激。采用免疫组织化学染色和蛋白质印迹法观察心肌中p-p38 MAPK、p-ERK和p-JNK的表达。
对照组灌注前后心脏功能未检测到显著变化,而UFPs灌注的心脏功能呈时间依赖性下降(均P < 0.05)。在UFPs处理组中,LVDP、+d/d、-d/d和CF分别从(82.6±2.1)mmHg、(1624±113)mmHg/s、(1565±116)mmHg/s、(12.0±0.2)mL/min统计学下降至(�6.8±4.4)mmHg、(1066±177)mmHg/s、(1082±134)mmHg/s、(8.7±0.3)mL/min(均P < 0.05)。此外,两组比较发现,与对照组相比,UFPs灌注在30和40分钟时导致心脏功能显著下降(均P < 0.05)。灌注结束时,UFPs组MDA水平从(0.98±0.14)nmol/L升高至(1.95±0.18)nmol/L,而SOD和TAOC分别从(12.50±1.87)U/mL和(6.83±1.16)U/mL降至(6.50±1.04)U/mL和(3.67±0.82)U/mL(均P < 0.001)。与这些变化一致,免疫组织化学和蛋白质印迹结果显示,与对照组相比,UFPs组心肌中p-p38 MAPK、p-ERK和p-JNK的水平显著升高(均P < 0.05)。
本研究结果表明,UFPs短期暴露于离体大鼠心脏对心脏功能有直接急性毒性作用,可能与抗氧化能力减弱和MAPK信号通路激活有关。